Skip to main content
logo
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.1727
+0.0041 (2.43%)
At close: Sep 2, 2026, 4:00 PM EDT
0.1671
-0.0056 (-3.24%)
Pre-market: Sep 3, 2026, 7:40 AM EDT

Vivos Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
20.917.4415.0313.816.0216.89
Revenue Growth
45.22%16.05%8.91%-13.87%-5.10%29.23%
Gross Profit
12.9410.549.028.2710.0212.6
Operating Income
-22.55-19.89-11.17-17.3-25.03-19.47
Net Income
-25.46-21.17-11.14-13.58-23.85-20.29
Earnings Per Share
-1.83-2.06-2.22-11.14-25.90-23.89
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.772.036.261.643.5224.03
Total Debt
12.5113.51.5122.411.27
Net Cash (Debt)
-10.73-11.474.75-0.351.1122.77
Net Cash Growth
-----95.14%34.58%
Net Cash Per Share
-0.77-1.120.95-0.291.2026.80

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.13-15.26-12.69-11.95-19.59-15.74
Capital Expenditures
-1.88-2.34-0.57-0.85-0.92-2.4
Free Cash Flow
-19.01-17.6-13.26-12.8-20.51-18.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.90%60.44%60.00%59.93%62.52%74.65%
Operating Margin
-107.90%-114.05%-74.32%-125.32%-156.21%-115.31%
Pretax Margin
-122.61%-121.71%-74.09%-98.42%-148.81%-120.15%
Profit Margin
-121.79%-121.37%-74.09%-98.42%-148.81%-120.15%
FCF Margin
-90.96%-100.92%-88.21%-92.74%-128.00%-107.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.171.051.681.080.583.07